September 12, 2026
Peptides Are Exploding. Payments Isn’t Ready

Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrite and Monitor It Peptides have moved from a niche scientific category into one of the fastest-growing areas of health, wellness, performance, longevity and medical commerce. Some are well-established prescription therapies. Others are being compounded. Others are sold […]

Read More
May 7, 2026
Research Peptides vs. Supplement Peptides: Where the Regulatory Line Gets Drawn

The peptide market sits at a crossroads that regulators, payment processors, and financial institutions are closely watching. A product marketed as a dietary supplement and the same compound sold for "research use only" may contain identical molecules — but they exist in entirely different regulatory worlds, and the consequences of misclassifying one as the other […]

Read More
May 6, 2026
Peptide Product Labeling

The FDA issued more than 50 warning letters to peptide companies in September 2025 alone. It followed those with additional enforcement actions in early 2026, targeting companies selling retatrutide, tirzepatide, and other compounds in research or with supplement-like positioning that the agency determined crossed the line into unapproved drug territory. For any business selling peptide […]

Read More
November 5, 2025
Collagen Peptides Show Promise as Anti-Obesity Supplement in Animal Research

A comprehensive systematic review and meta-analysis reveals that collagen peptide supplementation produces significant anti-obesity effects in rodent models. The research, analyzing 21 studies involving 339 animals, demonstrates meaningful improvements across multiple metabolic markers when animals consumed collagen peptides for at least three weeks. Substantial Body Weight and Food Intake Reductions The meta-analysis documented significant decreases […]

Read More
November 5, 2025
Peptide Synthesis Market Poised for Explosive Growth Through 2033

The global peptide synthesis market is experiencing dramatic expansion as pharmaceutical companies and research institutions accelerate investment in peptide-based therapeutics. Industry analysts project the market will nearly triple from $861 million in 2024 to $2.3 billion by 2033, representing an 11.4% compound annual growth rate. Major Manufacturing Capacity Expansions Signal Industry Confidence Recent capital investments […]

Read More
November 5, 2025
Cyanobacteria Study Reveals Hidden Protein Functions Through Small Peptide Discovery

A comprehensive genomic and proteomic study has identified previously unknown small proteins in five species of cyanobacteria. The research reveals that small open reading frame-encoded peptides play essential roles in photosynthesis, metabolism, stress responses, and cellular defense systems. Small Proteins With Big Functions Small open reading frames and their encoded peptides represent an emerging frontier […]

Read More
October 8, 2025
From Wild West to Watchdog: The Rising Regulatory Pressure on Nutraceuticals, Peptides & CBD

For years, the nutraceutical and CBD industries have operated in a gray zone—booming with innovation but light on oversight. That era is ending. During a recent Qredible Live Broadcast, CEO Brian Fitzpatrick and CRO Noah Fitzgerald discussed how rising regulatory pressure on nutraceuticals and adjacent markets like peptides and CBD is reshaping the health and […]

Read More
March 28, 2025
Managing Compliance in the Expanding Peptide Industry

Managing Compliance in the Expanding Peptide Industry The Line Between Research Peptide and Regulated Drug Is Where Compliance Breaks Down — and Where Qredible Starts The molecular world of peptides has captured significant attention across healthcare, cosmetics, and nutraceutical industries in recent years. These chains of amino acids—smaller than proteins but powerful in function—represent an […]

Read More
crossmenu